Relapsed multiple myeloma demonstrates distinct patterns of immune microenvironment and malignant cell-mediated immunosuppression

Immunotherapy has shown efficacy in relapsed multiple myeloma (MM). However, these therapies may depend on a functional tumor immune microenvironment (iTME) for their efficacy. Characterizing the evolution of the iTME over the disease course is necessary to optimize the timing of immunotherapies. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Visram, Alissa, Dasari, Surendra, Anderson, Emilie, Kumar, Shaji, Kourelis, Taxiarchis V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921408/
https://www.ncbi.nlm.nih.gov/pubmed/33649314
http://dx.doi.org/10.1038/s41408-021-00440-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921408/
https://www.ncbi.nlm.nih.gov/pubmed/33649314
http://dx.doi.org/10.1038/s41408-021-00440-4

Ejemplares similares